BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25637415)

  • 1. Towards understanding of nanoparticle-protein corona.
    Ge C; Tian J; Zhao Y; Chen C; Zhou R; Chai Z
    Arch Toxicol; 2015 Apr; 89(4):519-39. PubMed ID: 25637415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The "sweet" side of the protein corona: effects of glycosylation on nanoparticle-cell interactions.
    Wan S; Kelly PM; Mahon E; Stöckmann H; Rudd PM; Caruso F; Dawson KA; Yan Y; Monopoli MP
    ACS Nano; 2015 Feb; 9(2):2157-66. PubMed ID: 25599105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts.
    Lundqvist M; Stigler J; Elia G; Lynch I; Cedervall T; Dawson KA
    Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14265-70. PubMed ID: 18809927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of surface charge and shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/shell nanoparticles on the composition of the protein corona.
    Sakulkhu U; Mahmoudi M; Maurizi L; Coullerez G; Hofmann-Amtenbrink M; Vries M; Motazacker M; Rezaee F; Hofmann H
    Biomater Sci; 2015 Feb; 3(2):265-78. PubMed ID: 26218117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle-protein complexes mimicking corona formation in ocular environment.
    Jo DH; Kim JH; Son JG; Dan KS; Song SH; Lee TG; Kim JH
    Biomaterials; 2016 Dec; 109():23-31. PubMed ID: 27648757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the Chemical Nature of Nanoparticle-Protein Interactions.
    Baimanov D; Cai R; Chen C
    Bioconjug Chem; 2019 Jul; 30(7):1923-1937. PubMed ID: 31259537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silver nanoparticle protein corona and toxicity: a mini-review.
    Durán N; Silveira CP; Durán M; Martinez DS
    J Nanobiotechnology; 2015 Sep; 13():55. PubMed ID: 26337542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
    Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K
    ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Adsorption From Biofluids on Silica Nanoparticles: Corona Analysis as a Function of Particle Diameter and Porosity.
    Clemments AM; Botella P; Landry CC
    ACS Appl Mater Interfaces; 2015 Oct; 7(39):21682-9. PubMed ID: 26371804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles.
    Monopoli MP; Walczyk D; Campbell A; Elia G; Lynch I; Bombelli FB; Dawson KA
    J Am Chem Soc; 2011 Mar; 133(8):2525-34. PubMed ID: 21288025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles.
    Hu Z; Zhang H; Zhang Y; Wu R; Zou H
    Colloids Surf B Biointerfaces; 2014 Sep; 121():354-61. PubMed ID: 24974013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: impact on macrophage uptake.
    Lartigue L; Wilhelm C; Servais J; Factor C; Dencausse A; Bacri JC; Luciani N; Gazeau F
    ACS Nano; 2012 Mar; 6(3):2665-78. PubMed ID: 22324868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century.
    Lynch I; Cedervall T; Lundqvist M; Cabaleiro-Lago C; Linse S; Dawson KA
    Adv Colloid Interface Sci; 2007 Oct; 134-135():167-74. PubMed ID: 17574200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma protein adsorption and biological identity of systemically administered nanoparticles.
    Chen D; Ganesh S; Wang W; Amiji M
    Nanomedicine (Lond); 2017 Sep; 12(17):2113-2135. PubMed ID: 28805542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication of corona-free nanoparticles with tunable hydrophobicity.
    Moyano DF; Saha K; Prakash G; Yan B; Kong H; Yazdani M; Rotello VM
    ACS Nano; 2014 Jul; 8(7):6748-55. PubMed ID: 24971670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histidine adsorption on TiO2 nanoparticles: an integrated spectroscopic, thermodynamic, and molecular-based approach toward understanding nano-bio interactions.
    Mudunkotuwa IA; Grassian VH
    Langmuir; 2014 Jul; 30(29):8751-60. PubMed ID: 24978817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Recognition of Nanoparticle Protein Corona and Modified Low-Density Lipoprotein by Macrophage Receptor with Collagenous Structure.
    Lara S; Perez-Potti A; Herda LM; Adumeau L; Dawson KA; Yan Y
    ACS Nano; 2018 May; 12(5):4930-4937. PubMed ID: 29668255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model system to study the influence of aggregation on the hemolytic potential of silica nanoparticles.
    Thomassen LC; Rabolli V; Masschaele K; Alberto G; Tomatis M; Ghiazza M; Turci F; Breynaert E; Martra G; Kirschhock CE; Martens JA; Lison D; Fubini B
    Chem Res Toxicol; 2011 Nov; 24(11):1869-75. PubMed ID: 21928780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling of a single nanoparticle interaction with the human blood plasma proteins.
    Skakauskas V; Katauskis P
    J Biol Phys; 2018 Dec; 44(4):605-617. PubMed ID: 30209704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of human arylamine N-acetyltransferase 1 with different nanomaterials.
    Deng ZJ; Butcher NJ; Mortimer GM; Jia Z; Monteiro MJ; Martin DJ; Minchin RF
    Drug Metab Dispos; 2014 Mar; 42(3):377-83. PubMed ID: 24346836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.